Display options
Cite
Tini G, Duso BA, Bellerba F, et al. Semantic and Geographical Analysis of COVID-19 Trials Reveals a Fragmented Clinical Research Landscape Likely to Impair Informativeness. Front Med (Lausanne). 2020;7:367doi: 10.3389/fmed.2020.00367.
Tini, G., Duso, B. A., Bellerba, F., Corso, F., Gandini, S., Minucci, S., Pelicci, P. G., & Mazzarella, L. (2020). Semantic and Geographical Analysis of COVID-19 Trials Reveals a Fragmented Clinical Research Landscape Likely to Impair Informativeness. Frontiers in medicine, 7367. https://doi.org/10.3389/fmed.2020.00367
Tini, Giulia, et al. "Semantic and Geographical Analysis of COVID-19 Trials Reveals a Fragmented Clinical Research Landscape Likely to Impair Informativeness." Frontiers in medicine vol. 7 (2020): 367. doi: https://doi.org/10.3389/fmed.2020.00367
Tini G, Duso BA, Bellerba F, Corso F, Gandini S, Minucci S, Pelicci PG, Mazzarella L. Semantic and Geographical Analysis of COVID-19 Trials Reveals a Fragmented Clinical Research Landscape Likely to Impair Informativeness. Front Med (Lausanne). 2020 Jun 29;7:367. doi: 10.3389/fmed.2020.00367. eCollection 2020. PMID: 32695791; PMCID: PMC7336807.
Copy Download .nbib Format: NLM
Share it on

Front Med (Lausanne). 2020 Jun 29;7:367. doi: 10.3389/fmed.2020.00367. eCollection 2020.

Semantic and Geographical Analysis of COVID-19 Trials Reveals a Fragmented Clinical Research Landscape Likely to Impair Informativeness.

Frontiers in medicine

Giulia Tini, Bruno Achutti Duso, Federica Bellerba, Federica Corso, Sara Gandini, Saverio Minucci, Pier Giuseppe Pelicci, Luca Mazzarella

Affiliations

  1. Department of Experimental Oncology, IEO European Institute of Oncology IRCSS, Milan, Italy.
  2. Department of Hemato-Oncology, University of Milan, Milan, Italy.
  3. Division of Early Drug Development for Innovative Therapies, IEO European Institute of Oncology IRCCS, Milan, Italy.

PMID: 32695791 PMCID: PMC7336807 DOI: 10.3389/fmed.2020.00367

[No abstract available.]

Copyright © 2020 Tini, Duso, Bellerba, Corso, Gandini, Minucci, Pelicci and Mazzarella.

Keywords: COVID; design; endpoint; geography; trial

References

  1. N Engl J Med. 2020 May 7;382(19):1787-1799 - PubMed
  2. Lancet. 2020 Mar 28;395(10229):1054-1062 - PubMed
  3. Lancet. 2020 May 16;395(10236):1569-1578 - PubMed
  4. N Engl J Med. 2017 Jul 6;377(1):62-70 - PubMed
  5. Ann Intern Med. 2020 Jun 16;172(12):819-821 - PubMed
  6. Lancet. 2020 Apr 25;395(10233):1322-1325 - PubMed
  7. Int J Epidemiol. 2020 Feb 22;: - PubMed
  8. Clin Infect Dis. 2020 Apr 09;: - PubMed
  9. J Natl Cancer Inst. 2017 Jun 1;109(6): - PubMed
  10. J Immunother Cancer. 2020 Mar;8(1): - PubMed
  11. Lancet Glob Health. 2020 Jun;8(6):e754-e755 - PubMed
  12. Lancet Glob Health. 2020 Apr;8(4):e480 - PubMed
  13. Lancet Oncol. 2019 Jun;20(6):e336-e342 - PubMed
  14. JAMA. 2020 Mar 30;: - PubMed
  15. N Engl J Med. 2020 Jun 11;382(24):2327-2336 - PubMed
  16. JAMA. 2020 Apr 13;: - PubMed

Publication Types